Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

February 14, 2019

Primary Completion Date

July 6, 2022

Study Completion Date

July 6, 2022

Conditions
Multiple SclerosisRelapsing Multiple SclerosisAdvancing Multiple Sclerosis
Interventions
DRUG

Siponimod

Siponimod 2mg tablets taken once daily

Trial Locations (55)

19001

Abington Neurological Associates, Ltd, Abington

19090

Novartis Investigative Site, Willow Grove

19141

Novartis Investigative Site, Philadelphia

20854

Novartis Investigative Site, Rockville

22043

Novartis Investigative Site, Falls Church

27405

Novartis Investigative Site, Greensboro

27607

Novartis Investigative Site, Raleigh

28806

Novartis Investigative Site, Asheville

29650

Novartis Investigative Site, Greer

29707

Novartis Investigative Site, Old Point Station

32174

Novartis Investigative Site, Ormond Beach

32751

Novartis Investigative Site, Maitland

32806

Novartis Investigative Site, Orlando

32960

Novartis Investigative Site, Vero Beach

33136

Novartis Investigative Site, Miami

33351

Novartis Investigative Site, Sunrise

33487

Novartis Investigative Site, Boca Raton

33612

Novartis Investigative Site, Tampa

33761

MS & Neuromuscular Center of Excellence, Clearwater

34205

Novartis Investigative Site, Bradenton

34243

Novartis Investigative Site, Sarasota

34471

Novartis Investigative Site, Ocala

34677

Novartis Investigative Site, Oldsmar

35058

Novartis Investigative Site, Cullman

35209

Novartis Investigative Site, Birmingham

Alabama Neurology Associates, Homewood

37604

Novartis Investigative Site, Johnson City

38018

Novartis Investigative Site, Cordova

40503

Novartis Investigative Site, Lexington

40509

Novartis Investigative Site, Lexington

40513

Novartis Investigative Site, Lexington

45219

Novartis Investigative Site, Cincinnati

46256

Novartis Investigative Site, Indianapolis

48035

Novartis Investigative Site, Clinton Township

53188

Novartis Investigative Site, Waukesha

60422

Novartis Investigative Site, Flossmoor

63110

Novartis Investigative Site, St Louis

73104

Novartis Investigative Site, Oklahoma City

78258

Novartis Investigative Site, San Antonio

78681

Novartis Investigative Site, Round Rock

80209

Novartis Investigative Site, Denver

80528

Novartis Investigative Site, Fort Collins

80907

Novartis Investigative Site, Colorado Springs

85718

Novartis Investigative Site, Tucson

89128

Novartis Investigative Site, Las Vegas

92617

Novartis Investigative Site, Irvine

92835

Novartis Investigative Site, Fullerton

93710

Novartis Investigative Site, Fresno

98034

Novartis Investigative Site, Kirkland

98122

Novartis Investigative Site, Seattle

98405

Novartis Investigative Site, Tacoma

99202

Novartis Investigative Site, Spokane

07601

Novartis Investigative Site, Hackensack

44106-5028

Novartis Investigative Site, Cleveland

00968

Novartis Investigative Site, Guaynabo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY